Increased Vascular Contractility in Hypertension Results From Impaired Endothelial Calcium Signaling

Calum Wilson1, Xun Zhang1, Charlotte Buckley1

  • 1From the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.

Insights

Hypertension impairs endothelial cell calcium (Ca2+) signaling at myoendothelial projections, disrupting vascular tone regulation. This disruption leads to increased blood vessel contraction and heightened vascular reactivity in hypertensive rats.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Physiology
  • Hypertension Research

Background:

  • Endothelial cells regulate vascular tone via vasoactive factors.
  • Hypertension disrupts endothelial function, increasing vascular tone.
  • Calcium (Ca2+) signaling is crucial for endothelial-derived vasodilators, but its alteration in hypertension is poorly understood.

Purpose of the Study:

  • To investigate alterations in endothelial Ca2+ signaling at myoendothelial projections in hypertension.
  • To determine the impact of these Ca2+ signaling changes on vascular tone regulation.

Main Methods:

  • Comparison of vascular reactivity to phenylephrine in hypertensive (spontaneously hypertensive rat) and normotensive (Wistar Kyoto) rats.
  • Assessment of basal endothelial Ca2+ activity and its buffering effects.
  • Analysis of local endothelial inositol trisphosphate (IP3)-mediated Ca2+ signals, including amplitude, duration, frequency, site of origin, and spatial distribution relative to myoendothelial projections.

Main Results:

  • Hypertensive rats exhibit increased vascular reactivity to phenylephrine compared to normotensive rats.
  • Impaired Ca2+-dependent endothelial control limits basal vascular contraction in hypertension.
  • Buffering endothelial Ca2+ changes normalizes phenylephrine-induced contraction in both groups.
  • Hypertension is associated with smaller, shorter, less frequent, and spatially disorganized local endothelial IP3-mediated Ca2+ signals near myoendothelial projections.

Conclusions:

  • The organization of localized Ca2+ signaling circuits at myoendothelial projections is disrupted in hypertension.
  • This disruption of endothelial Ca2+ signaling contributes to the increased contractile responses observed in hypertension.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
818
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K